Sign in
4/A

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001724521-24-000057

Chief Financial Officer acquired 22,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Goeltz II Robert C. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-23 Grant or award : show line 1 in the form +22,000 73,831 D
Loading xslF345X05/wk-form4a_1708728574.xml…